The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Applications and Limitations of Dendrimers in Biomedicine
Open accessAbstract
Biomedicine represents one of the main study areas for dendrimers, which have proven to be valuable both in diagnostics and therapy, due to their capacity for improving solubility, absorption, bioavailability and targeted distribution. Molecular cytotoxicity constitutes a limiting characteristic, especially for cationic and higher-generation dendrimers. Antineoplastic research of dendrimers has been widely developed, and several types of poly(amidoamine) and poly(propylene imine) dendrimer complexes with doxorubicin, paclitaxel, imatinib, sunitinib, cisplatin, melphalan and methotrexate have shown an improvement in comparison with the drug molecule alone. The anti-inflammatory therapy focused on dendrimer complexes of ibuprofen, indomethacin, piroxicam, ketoprofen and diflunisal. In the context of the development of antibiotic-resistant bacterial strains, dendrimer complexes of fluoroquinolones, macrolides, beta-lactamines and aminoglycosides have shown promising effects. Regarding antiviral therapy, studies have been performed to develop dendrimer conjugates with tenofovir, maraviroc, zidovudine, oseltamivir and acyclovir, among others. Furthermore, cardiovascular therapy has strongly addressed dendrimers. Employed in imaging diagnostics, dendrimers reduce the dosage required to obtain images, thus improving the efficiency of radioisotopes. Dendrimers are macromolecular structures with multiple advantages that can suffer modifications depending on the chemical nature of the drug that has to be transported. The results obtained so far encourage the pursuit of new studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–222 of 222
Perspective: Dendrimer drugs for infection and inflammation
Shaunak, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.07.033 · Cited by 32
A Review of Synthesis, Characterization and Applications of Functionalized Dendrimers
Ebelegi, A. N., Allen, E. T., Ayawei, N., & Wankasi, D. (2017) · American Journal of Polymer Science · Cited by 32
Targeted conjugation of breast anticancer drug tamoxifen and its metabolites with synthetic polymers
Sanyakamdhorn, S., Agudelo, D., Bekale, L. A., & Tajmir‐Riahi, H. A. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.035 · Cited by 30
Markowicz-Piasecka, M., & Mikiciuk‐Olasik, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42866-8.00002-2 · Cited by 30
Emerging Opportunities in the Biomedical Applications of Dendrimers
Abd‐El‐Aziz, A. S., & Agatemor, C. (2017) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-017-0768-5 · Cited by 30
Synthesis and Antimicrobial Properties of a Ciprofloxacin and PAMAM-dendrimer Conjugate
Svenningsen, S. W., Frederiksen, R. F., Counil, C., Ficker, M., Leisner, J. J., & Christensen, J. B. (2020) · Molecules · doi:10.3390/molecules25061389 · Cited by 30
Dichwalkar, T., Patel, S., Bapat, S., Pancholi, P., Jasani, N., Desai, B., Yellepeddi, V., & Sehdev, V. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201600457 · Cited by 29
Wróblewska, M., & Winnicka, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160920277 · Cited by 28
Dąbrzalska, M., Janaszewska, A., Zabłocka, M., Mignani, S. M., Majoral, J., & Klajnert‐Maculewicz, B. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00108 · Cited by 28
Fruchon, S., & Poupot, R. (2018) · Molecules · doi:10.3390/molecules23061272 · Cited by 27
Morikawa, A. (2016) · Molecules · doi:10.3390/molecules21020219 · Cited by 26
Lee, Y.-J., Song, H., Yoon, Y. J., Park, S.-J., Kim, S., Han, D. C., & Kwon, B. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113920 · Cited by 26
Liu, C., Lee, W., Fung, C.-P., Cheng, N.-C., Liu, C.-L., Yang, S.-P., & Chen, S.-L. (1996) · Clinical Drug Investigation · doi:10.2165/00044011-199612020-00003 · Cited by 24
Dendrimers and the Development of New Complex Nanomaterials for Biomedical Applications
Gardikis, Κ., Micha‐Screttas, M., Demetzos, C., & Steele, B. R. (2012) · Current Medicinal Chemistry · doi:10.2174/0929867311209024913 · Cited by 23
Dendrimer‐entrapped metal colloids as imaging agents
Li, D., Wen, S., & Shi, X. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1331 · Cited by 21
Ma, J., & Yao, H. C. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2017_2331 · Cited by 21
Utilizing ethacrynic acid and ciclopirox olamine in liver cancer
Al‐Dali, A., Weiher, H., & Schmidt‐Wolf, I. G. H. (2018) · Oncology Letters · doi:10.3892/ol.2018.9472 · Cited by 21
Markowicz-Piasecka, M., Sikora, J., Szymański, P., Kozak, O., Studniarek, M., & Mikiciuk‐Olasik, E. (2015) · Journal of Nanomaterials · doi:10.1155/2015/394827 · Cited by 20
The application of NMR in tumor angiogenesis research
Dadiani, M., Furman‐Haran, E., & Degani, H. (2006) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2006.06.001 · Cited by 16
Design of peptide–dendrimer conjugates with tumor homing and antitumor effects
Kojima, C., Saito, K., & Kondo, E. (2018) · Research on Chemical Intermediates · doi:10.1007/s11164-018-3280-9 · Cited by 16
Nanobiomaterial-based delivery of drugs in various cancer therapies
Pandurangan, A. K., Kanagesan, S., Narayanaswamy, R., Esa, N. M., & Padmanabhan, P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42863-7.00011-6 · Cited by 9
Infections: The Emergency of the New Millennium
Petrosillo, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-25494-0_1 · Cited by 8
Cited by
Controlled Drug Delivery Systems: Current Status and Future Directions
Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,691
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
A comprehensive review on various techniques used for synthesizing nanoparticles
Kumari, S., Raturi, S., Kulshrestha, S., Chauhan, K., Dhingra, S., András, K., Thu, K., Khargotra, R., & Singh, T. (2023) · Journal of Materials Research and Technology · doi:10.1016/j.jmrt.2023.09.291 · Cited by 388
Advantages of Hyaluronic Acid and Its Combination with Other Bioactive Ingredients in Cosmeceuticals
Juncan, A. M., Moisă, D. G., Santini, A., Morgovan, C., Rus, L.-L., Vonica-Țincu, A. L., & Loghin, F. (2021) · Molecules · doi:10.3390/molecules26154429 · Cited by 353
Self-citationDuan, C., Yu, M., Xu, J., Li, B.-Y., Zhao, Y., & Kankala, R. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114643 · Cited by 335
Metadata
- Authors
- Chis, A. A., Dobrea, C., Morgovan, C., Arseniu, A. M., Rus, L. L., Butuca, A., Juncan, A. M., Totan, M., Vonica-Tincu, A. L., Cormos, G., Muntean, A. C., Muresan, M. L., Gligor, F. G., & Frum, A.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-09-01
- Volume
- 25
- Issue
- 17
- Pages
- 3982
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3082905666
- Cited by
- 467
- References
- 222
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.